ライフサイエンスコーパス: biological marker

1 lesterol stands out as a bright fluorescence biological marker.

2 in (GFP) are extensively studied as powerful biological markers.

3 ing contrast agents specifically targeted to biological markers.

4 metabolic disturbances calls for predictive biological markers.

5 sage, prior psychiatric history, and several biological markers.

6 , but not severity, could be correlated with biological markers.

7 of affected patients using genetic and other biological markers.

8 relation to other prognostic factors such as biological markers.

9 ocalcitonin, C-reactive protein, sepsis, and biological markers.

10 Regional CBF may also provide a useful biological marker across different types of psychopathol

11 Examples of compounds marketed as biological markers along with recent advances in definin

12 We review promising clinical, imaging, and biological markers, along with novel designs, for clinic

13 Our study established a link between a biological marker and impulsivity among offenders (and l

14 nerve fibre layer thickness may be used as a biological marker and may help to distinguish between op

15 Biological markers and alternative treatment regimens wi

16 The observed correlations between biological markers and brain activation provide new evid

17 ussed with regard to the utility of in vitro biological markers and genetic models of analgesia.

18 We measured biological markers and typed human leukocyte antigen gen

19 37.3% (P < .001), independent from age, sex, biological markers, and disease duration.

20 Tumor extension, biological markers, and treatments at initial PNET diagn

21 Biological markers are not yet clinically useful for ide

22 on task measured with fNIRS might serve as a biological marker associated with delirium in ESLD patie

23 We thus have identified a biological marker associated with familial mood disorder

24 characterized by its symptoms rather than by biological markers because we have only a limited knowle

25 on measurements and enables the discovery of biological markers (biomarkers).

26 Integrating relationships between biological markers, brain imaging and clinical parameter

27 c abnormal personality traits, plus numerous biological markers (cognitive, anatomical, and psychophy

28 Examination of dinoflagellate-specific biological markers (dinosteranes and 4alpha-methyl-24-et

29 a discrete trait and a correlated continuous biological marker (e.g., a disease precursor or associat

30 fication with phenotypic characteristics and biological markers (eg, electrophysiological changes) mi

31 ce spectroscopy GABA measures may serve as a biological marker for a subtype of MDD.

32 that MRI findings may potentially serve as a biological marker for bipolar disorder.

33 ole for these Abs, measurable in blood, as a biological marker for clinical activity.

34 indicating that FOXP3 expression is a valid biological marker for human T(reg) cells even in the tum

35 assay may prove to be a useful intermediate biological marker for identifying subjects at increased

36 Rectal pain sensitivity has been called a biological marker for irritable bowel syndrome, but this

37 ermining collagenase 3 levels as a potential biological marker for OA, we developed highly selective

38 We are proposing a translational clinical biological marker for patients diagnosed with Bipolar Di

39 studies are needed to establish an objective biological marker for potential diagnostic usage in seve

40 proach has practical potential as a scalable biological marker for sports-related concussion and othe

41 s part of a growing effort to identify early biological markers for ASD.

42 uest has been stymied by a lack of validated biological markers for characterizing and distinguishing

43 ws great potential for providing much-needed biological markers for diagnosing, tracking, and predict

44 y important roles in vaccine development, as biological markers for disease diagnosis, and for analys

45 ingle-photon emission computed tomography as biological markers for following the progression of Park

46 The studies of biological markers for genetic vulnerability to schizoph

47 primitive neuroectodermal tumours prognostic biological markers have been identified that are undergo

48 ortance of studying the relationship between biological markers, impulsivity and criminal behavior.

49 lung, and skin tumors, suggest its use as a biological marker in cancer.

50 uid where it has the potential to serve as a biological marker in human neuronal disorders.

51 elationship is the first instance in which a biological marker in T-lineage ALL has been unequivocall

52 signal the onset of diseases and be used as biological markers in diagnostics.

53 erved in trials using intermediate end point biological markers in humans, in which beta-carotene has

54 ET) and computed tomography (CT), identified biological markers in mice and patients that provide a r

55 Moreover, the utility of biological markers in predicting threshold levels is unc

56 r2, alters toxin-induced expression of known biological markers in the AhR signaling pathway.

57 Biological markers including the neutrophil-lymphocyte r

58 Long-lived men also exhibited several biological markers indicative of greater insulin sensiti

59 robe targeted at alpha(v)beta(3) integrin, a biological marker known to modulate angiogenesis, was de

60 ated further by looking at valuable specific biological markers like troponin I and natriuretric pept

61 IONALE: Leukocyte telomere length (LTL) is a biological marker of aging, and shorter LTL is associate

62 Leukocyte telomere length (LTL) is a biological marker of aging, and shorter LTL is associate

63 nic stress is measured by allostatic load, a biological marker of cumulative wear and tear on the bod

64 It is unknown whether PMP22 can be used as a biological marker of disease progression and therapy eff

65 contributes to VEE virus virulence and is a biological marker of epizootic potential.

66 recent attention as a sensitive and specific biological marker of ethanol consumption.

67 tion in studies of DNA adduct formation as a biological marker of exposure to carcinogens and for env

68 vels of procollagen peptide III (PCP III), a biological marker of fibroproliferation, and with increa

69 amocortical mechanisms and could represent a biological marker of illness.

70 eukocyte telomere length (LTL) is a putative biological marker of immune system age, and there are de

71 The search for a unique biological marker of language-based learning disabilitie

72 Semen quality has been suggested to be a biological marker of long-term morbidity and mortality;

73 A self-reported intake in conjunction with a biological marker of macronutrient intake was required a

74 SD and SLI-history groups), but may act as a biological marker of persisting SLI.

75 , a measure of platelet size, is a potential biological marker of platelet function.

76 The most common biological marker of suicide is reduced concentrations o

77 aspartate receptors, represents a precocious biological marker of the disease.

78 R levels at admission could provide an early biological marker of the outcome of cerebral malaria.

79 y useful platform for rapidly validating any biological marker of this common disease.

80 IL-6 is a biological marker of ventilator-associated lung injury t

81 ative to angiopoietin-1 with physiologic and biological markers of activated endothelium.

82 ese findings suggest that the 2 measures are biological markers of AD pathophysiology.

83 fect on chronological longevity and many key biological markers of aging in the absence of environmen

84 Chronological aging independent of biological markers of aging is the primary risk factor f

85 erived from land use regression modeling and biological markers of airway inflammation.

86 , the estimated energy balance, clinical and biological markers of cachexia, and survival.REE was mea

87 ermetabolism is correlated with clinical and biological markers of cancer cachexia and is associated

88 cies of CD8(+) CD28(null) T cells are useful biological markers of compromised immunocompetence, iden

89 ted dimethylarginines may serve as important biological markers of deleterious outcome in alcoholic h

90 There are few biological markers of delirium, perhaps related to the e

91 n-targeted metabolite profiling can identify biological markers of dietary exposure that lead to a be

92 e currently being explored as more sensitive biological markers of disease activity.

93 Moderate to weak correlation was found with biological markers of endothelial activation.

94 and health is hindered by the lack of robust biological markers of food exposure.

95 a virus vaccine responses and can be used as biological markers of immunosenescence.

96 The identification of biological markers of impulsivity may lead to a better u

97 ides a potential strategy for development of biological markers of lipid modification of proteins fol

98 toward identification of early clinical and biological markers of long-term risk as well as avenues

99 on the activation of nuclear factor-kappaB, biological markers of neuronal injury, and neurobehavior

100 in vivo magnetic resonance imaging (MRI) and biological markers of oxidative stress and inflammation,

101 esearch has focused on the identification of biological markers of response to antidepressant treatme

102 isorders, longitudinal high-risk research on biological markers of risk has become a priority.

103 ponsible for susceptibility to CHD, specific biological markers of stress are increasingly being meas

104 The identification of biological markers of successful treatment response may

105 letal function described here will be useful biological markers of the functional effects of BCR/ABL

106 ponse in individual patients, review MRI and biological markers of treatment response, and summarise

107 al clinical disorders, they might constitute biological markers of vulnerability, linking exposure to

108 ts but are also associated with quantitative biological markers or quantitative risk factors.

109 Use of biological markers, or biomarkers, potentially offers a

110 example, an abnormal circulating level of a biological marker pertinent to the study drug; and c) pa

111 Numerous reports suggest that biological markers predict survival in patients undergoi

112 Although the prevailing view is that basic biological markers regulate this circadian modulation, b

113 rther studies with physiologic, genetic, and biological markers related to these phenotypes will be n

114 Because AF identifies these characteristic biological markers so specifically, autofluorescence met

115 going efforts toward identification of early biological markers specific to subphenotypes of ASD.

116 ld-type (WT) mice in the following important biological markers: spontaneous eschar separation, thinn

117 In addition, the biological marker studied here provided additional predi

118 Of all the biological markers studied, only increased density of CD

119 may make this group a homogeneous sample for biological marker studies.

120 Putative schizophrenia-associated biological markers, such as abnormal evoked response, oc

121 exia nervosa after recovery could indicate a biological marker that alters the normal motivation to e

122 A biological marker that helps to objectively define the d

123 hite matter abnormalities may be a heritable biological marker that indicates increased vulnerability

124 Identification of a biological marker that might improve these odds could ha

125 A biological marker that would allow clinicians to determi

126 A biological marker that would allow clinicians to determi

127 Currently there are no prognostic biological markers that accurately predict conversion of

128 The availability of robust quantitative biological markers that are correlated with qualitative

129 A more reliable approach would be to use biological markers that are specific for SHS exposure an

130 Universal biological markers that clearly identify potentially met

131 The identification of biological markers that define subtypes of major depress

132 se who are sensitized, there are no specific biological markers that differentiate between allergic a

133 isorder and those with pure ADHD to identify biological markers that distinguish these clinically ove

134 social factors in cancer and concentrates on biological markers that may mediate such relationships.

135 This research field critically needs biological markers that specifically identify the reside

136 esign of clinical trials, the development of biological markers, the advent of genetic animal models,

137 the deformation of the tissue directly from biological markers, thus providing 3D cellular scale inf

138 A widely used biological marker to identify the active form of ATM is

139 There is a lack of biological markers to evaluate the effectiveness of anti

140 e intra-alveolar space suggests the need for biological markers to guide response to therapy.

141 ing candidates for applications ranging from biological markers to organic light-emitting diodes (OLE

142 t GRN mutation status and could be used as a biological marker, we optimized a GRN ELISA and studied

143 Biological markers were measured before challenge.

144 We suggest that a low HVA level is a biological marker with modest association to the diagnos

145 ic foci provide a clinically relevant set of biological markers with potential importance for develop